[Research progress in epigenetic pharmacological effects of rhein].

Zhongguo Zhong Yao Za Zhi

Key Laboratory for Metabolic Diseases in Chinese Medicine, Nanjing University of Chinese Medicine Nanjing 210023, China Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China.

Published: December 2023

Rhein, which is one of the main active components of Rheum palmatum, has a range of pharmacological activities such as the regulation of the metabolism of glucose and lipids, anti-inflammatory, anti-tumor, anti-fibrosis, etc. Epigenetics refers to the heritable variation of gene expression without altering the DNA sequence. It is involved in the emergence and development of inflammation, renal fibrosis, diabetes, cancer, atherosclerosis, and other diseases, thus becoming a new strategy for the treatment of many di-seases. A series of studies have shown that epigenetic modification may be a common molecular mechanism of various pharmacological effects of rhein. This paper summarized the effects of rhein on the regulation of epigenetic modification and its underlying mechanisms, which involve the regulation of DNA methylation, protein acetylation, and RNA methylation, so as to provide a basis for the development and application of rhein.

Download full-text PDF

Source
http://dx.doi.org/10.19540/j.cnki.cjcmm.20230927.602DOI Listing

Publication Analysis

Top Keywords

pharmacological effects
8
epigenetic modification
8
effects rhein
8
[research progress
4
progress epigenetic
4
epigenetic pharmacological
4
effects rhein]
4
rhein
4
rhein] rhein
4
rhein main
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!